15.10
Avantor Inc stock is traded at $15.10, with a volume of 9.42M.
It is down -0.98% in the last 24 hours and down -8.54% over the past month.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
See More
Previous Close:
$15.25
Open:
$15.17
24h Volume:
9.42M
Relative Volume:
1.20
Market Cap:
$10.60B
Revenue:
$6.82B
Net Income/Loss:
$309.60M
P/E Ratio:
33.56
EPS:
0.45
Net Cash Flow:
$747.20M
1W Performance:
+2.72%
1M Performance:
-8.54%
6M Performance:
-39.04%
1Y Performance:
-38.06%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVTR
Avantor Inc
|
15.10 | 10.60B | 6.82B | 309.60M | 747.20M | 0.45 |
![]()
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-17-25 | Downgrade | UBS | Buy → Neutral |
Aug-28-24 | Initiated | Wells Fargo | Overweight |
Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
Sep-28-23 | Initiated | Bernstein | Mkt Perform |
Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
Dec-14-22 | Initiated | Deutsche Bank | Hold |
Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
Oct-15-21 | Resumed | Cowen | Outperform |
Aug-30-21 | Resumed | Raymond James | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
Jun-04-21 | Initiated | Goldman | Buy |
Apr-29-21 | Upgrade | Stifel | Hold → Buy |
Mar-03-21 | Initiated | Barclays | Overweight |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-14-20 | Initiated | Morgan Stanley | Overweight |
Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jan-07-20 | Initiated | Citigroup | Buy |
Nov-15-19 | Initiated | Stifel | Hold |
Aug-02-19 | Initiated | Cleveland Research | Neutral |
Jun-14-19 | Initiated | Janney | Buy |
Jun-12-19 | Initiated | Raymond James | Outperform |
Jun-11-19 | Initiated | Goldman | Buy |
Jun-11-19 | Initiated | Guggenheim | Buy |
Jun-11-19 | Initiated | JP Morgan | Overweight |
Jun-11-19 | Initiated | Jefferies | Buy |
Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
Jun-11-19 | Initiated | Piper Jaffray | Neutral |
Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
Jun-11-19 | Initiated | Robert W. Baird | Outperform |
Jun-11-19 | Initiated | SunTrust | Buy |
Jun-11-19 | Initiated | UBS | Buy |
Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
BofA Securities Cuts Price Target on Avantor to $20 From $25 - marketscreener.com
Avantor: Expansion Unveiled, Now What? - timothysykes.com
Avantor (AVTR) Receives a Buy from Barclays - The Globe and Mail
Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks - Yahoo Finance
RBC Cuts Price Target on Avantor to $24 From $29, Keeps Outperform Rating - MarketScreener
Avantor stock hits 52-week low at $15.36 amid market challenges - Investing.com Canada
3 Reasons AVTR is Risky and 1 Stock to Buy Instead - Yahoo Finance
Avantor Unveils Advanced Fluid Handling Solutions at INTERPHEX - MSN
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025 - ACN Newswire
The past three years for Avantor (NYSE:AVTR) investors has not been profitable - simplywall.st
Avantor wins bioprocessing awards at Asia-Pacific Biopharma Excellence Awards 2025 - Express Pharma
Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX - PR Newswire
Avantor’s Jerry Keybl Discusses Trends in Biomanufacturing, Navigating Market Shifts - Genetic Engineering and Biotechnology News
Avantor, Inc. (NYSE:AVTR) Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Avantor to Announce Q1 2025 Financial Results on April 25 - MSN
Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 - The Malaysian Reserve
Avantor® to Report First Quarter 2025 Earnings on Friday, April - GuruFocus
Avantor® To Report First Quarter 2025 Earnings On Friday, April 25, 2025 - MarketScreener
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now - MSN
Avantor, TriLink Partner to Expand Nucleic Acid Access in EMEA - Contract Pharma
Sterile Bottles Market Is Booming Worldwide 2025-2032 |Avantor - openPR.com
Avidin Market Size, Scope 2031 by Key Companies- AnaSpec Inc, - openPR
Avantor provides first look at recently completed hydration expansion - European Pharmaceutical Manufacturer
Long Term Trading Analysis for (AVTR) - Stock Traders Daily
Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 - PR Newswire
Why Avantor Inc. (AVTR) Went Down On Wednesday? - MSN
Avantor, Inc. (AVTR): Among the Undervalued Stocks with the Highest Upside Potential - Insider Monkey
U.S. Indexes Closed Mixed Wednesday As Rocket Cos. Led, Avantor Lagged - Barron's
At US$17.28, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely? - Simply Wall St
Why Avantor, Inc. (AVTR) Is Plunging So Far In 2025 - MSN
Avantor: Mundane Business, Solid Cash Flow, Potential New Risks (NYSE:AVTR) - Seeking Alpha
Avantor at TD Cowen Healthcare Conference: Strategic Growth Insights - Investing.com
Avantor at TD Cowen Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com UK
Citigroup Issues Pessimistic Forecast for Avantor (NYSE:AVTR) Stock Price - Defense World
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference - GuruFocus.com
Avantor CEO to Speak at TD Cowen’s 45th Annual Health Care Conference - MSN
Dynasty Wealth Management LLC Has $717,000 Stock Holdings in Avantor, Inc. (NYSE:AVTR) - MarketBeat
Truist Financial Corp Trims Holdings in Avantor, Inc. (NYSE:AVTR) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 30,500 Shares of Avantor, Inc. (NYSE:AVTR) - MarketBeat
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):